Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT06521255 · RECRUITING
Trial details
- NCT number
- NCT06521255
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2028-09-01
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.